Amundi
NUTX

Amundi’s Nutex Health NUTX Stock Holding History

Amundi’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-91
Closed -$23K – 2102
2022
Q4 		$23K Buy
+91
New +$17.5K ﹤0.01% 1781

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Amundi's NUTX Position: Q1 2023 in Review

Amundi sold out of Nutex Health (NUTX) in Q1 2023, closing a stake of 91 shares — an estimated $23K sold.

Amundi first reported a position in NUTX in Q4 2022 and held it in 1 quarter. The position peaked at $23K in Q4 2022. 82 funds tracked by Wall St. Rank hold NUTX as of Q1 2023.

  • Amundi reported no remaining Nutex Health position as of Q1 2023 after selling out during the quarter.
  • Amundi sold 91 Nutex Health shares in Q1 2023, an estimated $23K.
  • Amundi first reported a position in Nutex Health in Q4 2022 and held it in 1 quarter.
  • Amundi's Nutex Health position peaked at $23K in Q4 2022.
  • 82 funds tracked by Wall St. Rank held Nutex Health as of Q1 2023.

Based on Amundi's 13F filing for Q1 2023, filed 15 May 2023.